A novel gene and protein product function-based classification for syndromic epidermal differentiation disorders, previously known as ichthyosis, is transforming treatment approaches. This paradigm groups disorders by shared mechanisms, suggesting that similar diseases could benefit from grouped therapeutic regimens and new targeted interventions. Updated classification offers clinicians enhanced precision and lays the groundwork for future, mechanism-driven dermatologic care. To learn more Click Here ##Reference## Paller AS, Teng J, Mazereeuw-Hautier J, et al. Syndromic epidermal differentiation disorders: a new classification toward pathogenesis-based therapy.
Br J Dermatol. 2025;193(4):592-618. doi:10.1093/bjd/ljaf123## Which approach is most promising for personalizing ichthyosis management? a) Mechanism-based classification b) Symptom-based management only c) Clinical phenotype…
